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Host Control of HIV-1 Parasitism in T Cells
by the Nuclear Factor of Activated T Cells
With the exception of the lentiviruses, productive in-
fection of target cells by most retroviruses is dependent
on proliferation of the infected cell. It has been sug-
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gested that the block to the integration of oncoretrovi-²Department of Microbiology and Immunology
ruses, such as murine and avian leukemia viruses, inStanford University School of Medicine
nondividing cells is at the level of nuclear entry (Roe etStanford, California 94305
al., 1993). Cell division and concomitant nuclear mem-³Department of Biology
brane dissolution is thought to allow these virions ac-Massachusetts Institute of Technology
cess to appropriate chromosomal DNA substrates. Len-Cambridge, Massachusetts 02139
tiviruses, however, can infect nonproliferating cell types§Rockefeller University
such as macrophages and other terminally differentiatedNew York, New York 10021
cells (Langhoff et al., 1991; Weinberg et al., 1991). This‖Systemix, Inc.
retroviral subgroup overcomes the need for cell divisionPalo Alto, California 94303
by actively importing the preintegration complex through
the nuclear pores (Heinzinger et al., 1994; Gallay et al.,
1995, 1997).
Summary Differences exist in the relative ability of HIV-1 to inte-
grate into the host DNA of different types of nondividing
Post HIV-1 entry, productive HIV-1 infection of primary cells. Thus, it is important to understand at which steps
T cells requires overcoming several cellular blocks to HIV-1 replication is blocked prior to its integration in
provirus establishment and replication. Activation of certain cell types but not others. For instance, post entry
unknown host intracellular events overcomes such in- of HIV-1 to the cytoplasm, reverse transcription and
hibitory steps and is concomitant with HIV-1 replica- integration are efficiently accomplished in macrophages
tion. We show that the transcription factor NFATc was independent of the activation or cell division status of
sufficient as a cellular factor to induce a highly permis- the cell (Heinzinger et al., 1994). In strong contrast, pro-
sive state for HIV-1 replication in primary CD41 T cells. ductive infection by HIV-1 is not immediately established
NFATc overcame a blockade at reverse transcription in quiescent primary CD41 T cells (comprising the major-
and permitted active HIV-1 replication. Pharmacologic ity of circulating T cells in vivo) (Folks et al., 1986; Zack
blockade of endogenous NFAT activity by FK506 or et al., 1990). In quiescent T cells HIV-1 entry occurs effi-
CsA inhibited synthesis of reverse transcription and ciently, but HIV-1 core proteins and virus nucleic acids
also potently blocked HIV-1 replication. T cells there- can be harbored in the cytoplasm for up to 2 weeks
fore can become competent for HIV-1 replication by without virus production until T cells are activated by
control of regulated host factors such as the NFATc antigenic or other costimulatory processes (Zagury et
transcription factor. The host mechanisms regulated al., 1986; Zack et al., 1988, 1992; Stevenson et al., 1990).
by such permissivity factors are potential targets for Several groups have investigated the events that oc-
anti-HIV-1 therapy. cur after HIV-1 entry into the cytoplasm of quiescent
CD41 T cells. Some studies suggest that the synthesis
of full-length viral DNA occurs only in activated cells andIntroduction
that viral reverse transcription prematurely terminates in
quiescent T cells, proceeding convincingly only to theHuman immunodeficiency virus 1 (HIV-1) is the etiologic
synthesis of the minus strand of HIV-1 DNA (Zack etagent of acquired immunodeficiency syndrome (AIDS)
al., 1990). Others proposed that full-length viral DNA is(Barre Sinoussi et al., 1983; Gallo et al., 1984). After
synthesized in quiescent T cells, but that the integrationtransmission to a host, HIV-1 initiates infection of target
of the HIV-1 DNA is blocked due to lack of viral DNAcells through the binding of its gp120 envelope protein
ATP-dependent import into the nucleus (Bukrinsky etto host receptors such as CD4 and one of several core-
al., 1991, 1992). It has also been reported that completeceptors (Moore, 1997). After entry of the HIV-1 nucleo-
viral reverse transcription and nuclear translocation ofprotein core to the cytoplasm of a target cell, the viral
the preintegration complex occur in quiescent T cells,RNA genome is converted to a DNA copy by a series
but are blocked from transcribing in the absence of Tof steps that employ the virally encoded reverse tran-
cell activation (Spina et al., 1995). Therefore, all thesescriptase. As reverse transcription proceeds, the dou-
studies suggest that after HIV-1 entry additional hostble-stranded viral DNA, bound with viral integrase pro-
factors must be provided concomitant with T cell activa-tein, forms a preintegration complex that is transported
tion to permit HIV-1 replicationÐincluding unknown fac-from the cytoplasm to the nucleus. After integration into
tors that permit complete reverse transcription and inte-host chromatin, HIV-1 gene expression and virion matu-
gration of HIV-1 DNA into the host genome.ration can be regulated by a variety of cellular and viral
These prior studies demonstrate conclusively thatproteins.
early aspects of HIV-1 replication depend absolutely
upon the state of T cell activation, while stopping short
of elucidating the initiating factors involved. We there-# To whom correspondence should be addressed (e-mail: gnolan@
CMGM.stanford.edu). fore set out to focus on the earliest events in T cell
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activation that regulate a first apparent intracellular
block, namely reverse transcription, observed by some
of these groups. One critical set of transcriptional regu-
lators in early T cell commitment processes is the nu-
clear factor of activated T cells (NFAT). NFAT is at pres-
ent a four-member family of genes related to the Rel/
NF-kB proteins (Northrop et al., 1993; Nolan, 1994; Rao
et al., 1997). We show here that one member of this
family, NFATc, can overcome a blockade to HIV-1 re-
verse transcription and is sufficient to enable productive
HIV-1 infection of primary T cells. This provides an un-
derstanding of the mechanism by which HIV-1 depends
upon key early activation factors preexisting in host T
cells, illustrating a classic case of host control of para-
sitism.
Results
Figure 1. PHA Stimulation Induces NFATc Expression but Not NF-HIV-1 can replicate in PHA-stimulated human primary T
kB Expression in Human Primary PBMC
cells but does not replicate in nonstimulated quiescent
Human primary PBMC were stimulated with or without PHA for 3
primary T cells (Folks et al., 1986; Zagury et al., 1986). days. Nuclear extracts from 3 3 106 cells were separated by SDS-
This suggests that T cell factors that are regulated by PAGE and analyzed by Western blot using an anti-NFATc mono-
PHA stimulation are involved in early steps of HIV-1 clonal antibody (upper) or an anti-NF-kB, p65 polyclonal antibody
(lower). Size markers are shown on left.proviral establishment and replication. We assayed two
transcription factors, NFATc and NF-kB, as candidate
cellular factors associated with T cell activation whose 2A). Flow cytometric purification of transduced cells re-
induction might be causal to HIV-1 provirus establish- sulted in cell populations that were over 98% positive for
ment and replication. Both of these cellular factors are the transduced constructs. The sorted cells consisted of
known to be able to enhance HIV-1 gene expression 91%±94% CD41/CD31 cells. The CD41 cells were 99.9%
through regions within the kB regulatory elements of and 99.7% positive for CD31 in both the control and
the HIV-1 LTR (Nabel and Baltimore, 1987; Kinoshita et NFATc-expressing cells, respectively. We did not detect
al., 1997). Both molecules are members of the extended cells expressing CD141 (a marker for macrophages/
family of Rel transcription factors (Grilli et al., 1993; No- monocytes) or CD191 (a marker for B cells) in either
lan, 1994). NFATc has been implicated as the primary population (Table 1). Thus, these selected CD41 cells
calcium-activated transcription factor controlling IL-2 are a highly pure population of CD31 T cells and contain
gene expression and critical T cell commitment pro- few, if any, CD141 monocytes/macrophages.
cesses. Blockade of NFATc activation by pharmacologic We confirmed the expression of transduced NFATc
agents, such as cyclosporin A (CsA) or FK506, inhibits in the primary CD41 T cells by Western blot analysis of
T cell activation and has been shown to inhibit HIV-1 nuclear extracts from control CD41 T cells and trans-
replication (Karpas et al., 1992; Thali et al., 1994; Thom- duced NFATc-expressing CD41 T cells at 3 days, 15
son and Bonham, 1995; Borvak et al., 1996). NF-kB has days, and 21 days after a second PHA stimulation. The
been broadly implicated in cellular activation cascades expression level of transduced NFATc was not grossly
and has been associated especially with tumor necrosis altered, and NF-kB expression was not affected by
factor a (TNFa)±induced activation of HIV-1 (Grilli et al., NFATc expression or by PHA stimulation (Figure 2B).
1993; Chen et al., 1997). Thus, NFATc did not lead to an enhancement of NF-kB
We first examined the subcellular expression profile expression in the nucleus, confirming earlier reports with
of NFATc and NF-kB after PHA stimulation of human T cell lines (Kinoshita et al., 1997) and indicating that
peripheral blood mononuclear cells (PBMCs). In non- NFATc effects studied here are not indirectly attributable
stimulated PBMC after 3 days culture with interleu- to NF-kB. Endogenous NFATc expression, which was
kin-2 (IL-2), the NF-kB p65 subunit was observable in induced by PHA stimulation, decreased in the control
the nucleus at a preexisting level (Figure 1). NFATc ex- cells over the time course, as would be expected. The
pression was observed only at very low levels. With splice isoform used in these studies gave the expected
PHA stimulation nuclear NFATc expression was greatly band size and differs from the endogenous NFATc splice
enhanced in PBMC, but NF-kB levels decreased some- isoform profile as representing only one of the three
what (Figure 1); this is confirmed with purified T cells major species (Figure 2B). Importantly, and as has been
(see below). Since PHA is known to greatly enhance observed by others, NFATc could under these condi-
HIV-1 replication, and NFATc is upregulated in PHA- tions overcome regulation of subcellular partitioning and
activated T cells, we further explored whether NFATc enter the nucleus (Rao et al., 1997).
might be causal in the control of HIV-1 replication in
primary T cells. NFATc Decouples HIV-1 Replication from Activation
Conditions were established to express NFATc in hu- and Proliferation of Primary CD41 T Cells
man PBMC (depleted of B cells, macrophage, and CD81 To determine whether HIV-1 replication in primary T cells
was affected by the expression of NFATc, the HIV-1T cells) using a retroviral gene delivery system (Figure
NFAT Overcomes an HIV-1 Preintegrative Block
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Figure 2. Transduction of NFATc Expression
into Primary CD41 T Cells Has No Influence
on Steady State of NF-kB p65
(A) NFATc and control retrovirus constructs.
The viral long terminal repeats are shown.
The NFATc transcription factor is inserted in
the vector as shown upstream of an IRES-
Lyt2a9 (murine CD8a9) cotranslation unit. The
negative control vector is as shown.
(B) Expression of NFATc and NF-kB in CD41 T
cells. After retroviral transduction, cells were
restimulated 12 days post first stimulation.
Nuclear extracts were analyzed by Western
blot using an anti-NFATc monoclonal anti-
body (upper) or an anti-NF-kB p65 (lower) at
3 days, 15 days, and 21 days post second
stimulation.
T-tropic strain NL4-3 was infected into NFATc-express- cells (data not shown), suggesting the effect is not lim-
ited to T-tropic HIV-1 strains.ing CD41 T cells and control CD41 T cells using the
experimental schedule shown in Figure 3A. The experi- NFATc is part of the normal T cell activation program.
We examined whether transduced NFATc was by itselfment consisted of two phases. The first phase provides
conditions for efficient gene transduction using the ret- leading to proliferation or activation of the CD41 T cells.
Over a time course of 18 days we did not observe anyrovirus gene delivery system. The second phase is the
experimental section for testing HIV-1 infection kinetics growth advantage or disadvantage due to NFATc ex-
pression in human primary CD41 T cells. The growthand biochemistry.
Over a time course of 18 days post HIV-1 infection, rate for both populations of cells showed only a 4-fold
expansion over the 18 days of this time course, in accor-HIV-1 replication was measured by a p24 enzyme-linked
assay (ELISA) (Figure 3B). Surprisingly, HIV-1 replication dance with expectations for primary T cells under these
kinds of culture conditions. As expected, secondarywas dramatic in the NFATc-transduced CD41 T cell pop-
ulation, even without PHA stimulation. However, in con- PHA stimulation significantly enhanced the growth rate,
especially during the first few days of induction (Figuretrol CD41 T cells we could not detect HIV-1 replication
unless PHA activation was provided. The replication 3C). Cell populations were comprised of over 80% living
cells through the last observed time point. Thus, al-level of HIV-1 in NFATc-expressing cells was at least
10-fold higher at the first time point than that in control though NFATc has been suggested to be necessary for
T cell proliferation, NFATc alone is not sufficient to drivecells secondarily stimulated by PHA. This proceeded
until a plateau was reached and virus count declined. T cell proliferation.
It has been reported that progression to the G1bHIV-1 replication in NFATc-expressing CD41 T cells was
enhanced by secondary PHA stimulation (Figure 3B). phase of the cell cycle might be important for HIV-1
replication (Korin and Zack, 1998). We therefore exam-Thus, NFATc can permit HIV-1 replication in human pri-
mary CD41 T cells. Similar results were observed when ined the cell cycle status of the control and NFATc-
transduced cells (Figure 3D) using 7-amino-actinomycinan M-tropic HIV-1 strain, YU-2, was infected into these
Table 1. Characterization of Cell Populations Transduced with NFATc and Control Recombinant Retrovirus
Positive Expression (%)
Unsorted Cells Sorted Cells
Lyt2 Lyt2 CD14
Retrovirus (Transduction (Transduction CD4 CD3 CD57 CD8 (Macrophage/ CD19
Vector Marker) Marker) (T Cell Sub Pop.) (T Cell) (NK Cell) (T Cell Sub Pop.) Monocyte) (B Cell)
Control 38.4 .98 91.4 91.2 4.4 0.3 ,0.01 ,0.01
NFATc 43.2 .98 94.8 94.5 4.0 0.5 ,0.01 ,0.01
The relative percentages of cells expressing CD4, CD3, CD57, and CD8 were analyzed by seven-parameter flow cytometry after transduction
with recombinant retroviruses. CD14 and CD19 were analyzed by four-color flow cytometry. Scatter gates were set for live cells, and a
propidium iodide gate was set to exclude dead cells from the analysis. Percentages therefore represent percent of living cells within the
population of cells analyzed. Recombinant retroviruses used were pBMN-control-IRES-Lyt2a9 and pBMN-NFATc-IRES-Lyt2a9. These were
transduced into PBMC depleted of cells expressing CD8 and CD19. Transduction was measured using anti-murine Lyt2a9 antibody as a
surrogate marker of retrovirus expression.
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Figure 3. NFATc Induces Productive HIV-1 Infection in Primary CD41 T Cells
(A) Time schedule of NFATc transduction and HIV-1 challenge experiments.
(B) p24 assay of transduced CD41 T cells after HIV-1 challenge. CD41 T cell transduced with the control recombinant retrovirus without (open
circles) or with PHA stimulation (open squares) and CD41 T cells transduced with NFATc recombinant retrovirus without (filled circles) or with
PHA stimulation (filled squares) were challenged with HIV-1 (NL4-3) at a dose of 400 TCID50 per 105 cells. p24gag proteins levels in culture
supernatant were assayed from four wells every 3 days post infection. Data are presented as the average 6 SD per 106 cells. Similar results
were observed in three independent experiments.
(C) Growth curve for control and NFATc-expressing CD41 T cells. At 3 days post second stimulation, 105 cells were seeded per well, control
CD41 T cell without restimulation (open circles), with PHA stimulation (open squares), and NFATc-expressing CD41 T cell without restimulation
(filled circles), with PHA stimulation (filled squares). XTT assays were performed (Kinoshita et al., 1997) using 4 wells per each group at every
3 days until 21 days post second stimulation. Data are presented as the average 6 SD.
(D) Cell cycle analysis of transduced CD41 T cells. Cell populations were as described in (B). Control CD41 T cells were stimulated with PHA
(A) or without PHA (C). NFATc-expressing CD41 T cells were stimulated with PHA (B) or without PHA (D). Cells (5 3 105) for each condition
were stained by 7AAD (DNA) and PY (RNA) for cell cycle analysis. The analysis was performed 3 days post secondary stimulation.
D (7AAD) and pyronin Y (Toba et al., 1995). As would be PHA stimulation. NFATc-expressing T cell populations
have cells in G1a/G1b, some cells in S, and some in G2/M.expected, even by day 3 PHA stimulation does induce
some modest progression of cells into G1a (Figure 3D, Thus, having a significant proportion of cells in G1b or
S/G2/M is insufficient to confer HIV-1 replication compe-panels A and B); NFAT expression in the presence of
PHA showed no differences from PHA-stimulated con- tency upon these cells. NFATc expression, in strong con-
trast, did confer replication competency in these cells,trol cells. Critically, however, NFATc expression (Figure
3D, panel D) did not by itself drive all the T cells into in a manner that is yet to be determined though could
involve such induced factors as DNA nucleotide levelsany phase of the cell cycle as compared to control cells
(Figure 3D, panel C) that had also received no secondary (Figure 3D, panel D) or other required factors.
NFAT Overcomes an HIV-1 Preintegrative Block
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NFATc expression by itself was not, however, capable
of activating most common T cell activation markers
or cytokines associated with T cell proliferation. T cell
induction is accompanied by changes in the expression
of numerous activation markers and cytokines, and
NFAT is thought to influence the activation program of
T cells. No differences were observed in the levels of
expression of the T cell activation markers CD25, CD38,
CD69, or HLA-DR between NFATc-expressing CD41 T
cells and control CD41 T cells. Also, no changes were
observed in the expression of intracellular cytokines
IL-2, IL-4, or IFNg (S. K., N. W., and G. P. N., unpublished
data).
Coreceptor variation also did not account for the all
or nothing difference we observed in the transduced T
cells. Since HIV-1 entry depends upon the presence of
appropriate coreceptors, we examined the expression
level of CCR5 (primarily M-tropic) and CXCR4 (primarily
T-tropic) with or without NFATc transduction. The tran-
script levels of the HIV-1 coreceptors CCR5 or CXCR4
were not changed by PHA stimulation or by NFATc ex-
pression (data not shown). CCR5 and CXCR4 protein
were present on control unstimulated cells as ascer-
tained by flow cytometry. After normalization for infec-
tion efficiency of retrovirus transduction, there was little
or no observable difference (data not shown) in expres-
sion levels of either coreceptor due to transduced NFATc
expression that could account for the all or nothing repli-
cation observed in the prior figures.
NFATc therefore activates a subset of the T cell pro-
gram, unlinked to known T cell activation markers, that
is sufficient to confer permissivity for HIV-1 replication.
Figure 4. NFATc Facilitates Completed Reverse Transcription ofNFATc Facilitates Complete Reverse
HIV-1 Viral DNATranscription of HIV-1
(A) Specific primer sets used to detect HIV-1 reverse transcriptionTo define an NFAT-dependent step that restricts estab-
products, as well as the expected sizes of PCR products, and spe-lishment of productive HIV-1 infection, we performed
cific probes used are shown against a schematic map of the 59DNA-dependent PCR with primer sets that distinguish
region of the HIV-1 genome.
salient stages of reverse transcription. Total cellular (B) PCR analysis of HIV-1 viral DNA synthesis. PCR amplification
DNA was prepared from HIV-1-infected control CD41 T using the indicated primer pairs was performed using cellular DNA
cells and NFATc-expressing CD41 T cells at 9 days post from 3.5 3 104 cells from HIV-1 noninfected (lane 1) or infected
(lane 2) PHA blasts, HIV-1 infected control CD41 T cell (lane 3), andHIV-1 challenge. The primer pair R/U5 can amplify the
NFATc-expressing CD41 T cell (lane 4). Cells were from the sameearliest reverse transcription product (minus-strand
healthy blood donor.strong-stop DNA); primer pairs U3/5NC and R/5NC were
(C) Southern blot analysis of PCR products. PCR products from U3/
used as specific primers only for the detection of com- 5NC and R/5NC primer pairs were hybridized using an HIV-1-specific
pleted double-stranded viral DNA (Figure 4A). probe. Lanes numbered are the same as described in (B). We repro-
The earliest reverse transcription product (139 bp) ducibly observed a weak PCR band (about 500 bp) in HIV-1-infected
PHA blast and NFATc-expressing CD41 T cells when the U3/5NCwas observed in all HIV-1-infected cells (Figure 4B, lanes
primer pair was used. This DNA is HIV-1 specific by Southern blot2, 3, and 4), but not in HIV-1-uninfected cells (Figure 4B,
analysis.lane 1). The U3/5NC and R/5NC specific PCR bands
are present in HIV-1-infected NFATc-expressing CD41
T cells but not in HIV-1-infected control CD41 T cells The prior experiments depended upon the introduc-
tion of exogenous NFATc to primary T cells. To confirm(Figure 4B, lanes 3, 4). The PCR products were con-
firmed as specific for HIV-1 by Southern blot analysis whether endogenous NFAT complexes are involved in
HIV-1 replication and reverse transcription of HIV-1, we(Figure 4C). Thus, post HIV-1 entry to target cells, re-
verse transcription initiates in control cells as well as in employed the well-characterized inhibitors of the NFAT
pathway, CsA and FK506. CsA and FK506 form com-cells ectopically expressing NFATc. Completed reverse
transcription only occurred in cells expressing trans- plexes with cyclophilin A and FK506-binding protein
(FKBP), respectively (Liu et al., 1991). These complexesduced NFATc or in PHA blasts infected with HIV-1. We
observed similar results with samples taken from a time specifically inhibit the activity of calcineurin, the calmod-
ulin-dependent protein phosphatase. Calcineurin is re-course at 1 day, 3 days, and 6 days post HIV-1 infection
(data not shown). quired to dephosphorylate NFATc or NFATp prior to
Cell
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earliest reverse transcription product were observed in
PHA-stimulated cells irrespective of CsA or FK506 treat-
ment. These results underscore a role of endogenous
activated NFAT in permitting a state allowing completed
reverse transcription in T cells.
Direct Effects of NFATc on Single Cell
Infectivity by HIV-1
We examined whether the observed NFATc-induced
HIV-1 replication is a direct or an indirect effect of ectopi-
cally expressed NFATc in human primary cells. To corre-
late NFATc expression with HIV-1 infectivity we engi-
neered an HIV-1 construct, derived from HXB2, in which
green fluorescent protein (GFP) was fused to the nef
reading frame. NFATc-expressing primary T cells and
control cells (see column 1, unsorted cells, Table 1) were
infected with HXB-GFP at 3 days post the second PHA
stimulation or mock stimulation. Five days post HXB-
GFP challenge, the expression of GFP and NFATc (via
measure of the Lyt-2a9 surrogate) was coanalyzed by
dual-color multiparameter FACS.
As expected, no observable HIV-1/GFP-positive pop-
ulation was seen using PHA blasts that had not been
challenged with HXB-GFP (Figure 6A), indicating no sig-
nificant background exists that would preclude sensitive
detection of rare populations of positive cells. There
was no obviously positive HIV-1/GFP signal in the con-
trol cells that had not received PHA stimulation but had
been challenged with HXB-GFP (Figure 6B). When these
control cells were stimulated with PHA, an HIV-1/GFP-
Figure 5. CsA and FH506 Inhibit Completed HIV-1 Reverse Tran-
positive population was observed (Figure 6C, rightscription
quadrants, 0.1% 1 0.53% 5 0.63%). Thus, in controlFreshly isolated CD41 T cells were treated under the indicated con-
cells that are not stimulated HIV-1 is not capable ofditions. HIV-1 challenge of these cells was performed at 3 days post
replication. This is consistent with the data in Figure 3Btreatment. At 6 days post HIV-1 challenge, cells were assayed. (A)
HIV-1 replication levels were determined by p24 ELISA under the and the literature, as replication requires an activation
indicated conditions. event such as that provided by PHA. Infection percent-
(B) The DNA samples from these cells were amplified by PCR using ages observed are consistent with cell death during
the indicated primer pairs. The figure indicates the percentage of
culture and differences in how MOI was originally deter-relative density of PCR products from U3/5NC primer pairs after
mined on freshly isolated PHA blasts and the culturesouthern hybridization as assayed by Molecular Dynamics Phos-
conditions used in these experiments for single cellphoimager analysis. b-actin as a control was used to check for
nonspecific changes in RNA levels. When we used higher concentra- analysis.
tions of CsA (4 mg/ml, 10 mg/ml) or FK506, target cell health was However, in the cell population that had been trans-
seriously damaged and these samples were not assayed further. duced with NFATc, even in the absence of PHA stimula-
tion, we observed a dramatic increase in the HIV-1/
their translocation to the nucleus (Flanagan et al., 1991; GFP-positive population (Figure 6D). This all or nothing
Jain et al., 1993). Freshly isolated target primary CD41 response is comparable to the replication enhancement
T cells were cultured in the presence of PHA and either observed in Figure 3B in the absence of stimulation but
CsA at 0 ng/ml, 100 ng/ml, 500 ng/ml, 1 mg/ml or FK506 in the presence of NFATc. NFATc (Figure 6D) was slightly
at 0 ng/ml, 10 ng/ml, 100 ng/ml, 500 ng/ml, 1 mg/ml. At more effective than PHA (Figure 6C) in conferring repli-
3 days post treatment the cells were challenged with cation competency at the single cell level (2.1-fold;
HIV-1 and replication levels were determined by p24 calculated by normalizing for infected cells in the con-
ELISA at day 6 post HIV-1 challenge. Figure 5A shows trol and NFATc transduced population, 0.33 4 [(0.1 3
that PHA-stimulated HIV-1 replication was strongly in- 15.44) 4 9.92]). This is in accordance with the data as
hibited by CsA (58%) or FK506 (81%). This supports presented in Figure 3B, which showed a near identical
the contention that PHA-induced endogenous NFAT is increase.
involved in HIV-1 replication. Does NFATc expression lead to specific HIV-1 replica-
If NFAT is relevant to the completion of reverse tran- tive capacity at the single cell level within a population
scription, as suggested using transduced NFATc, then of infected cells? We compared the GFP1 and GFP2
both CsA and FK506 should lead to a diminution in the cell populations expressing greater than 50 U of Lyt-2
levels of fully reverse-transcribed genomic HIV-1 DNA. (Figure 6D) versus those expressing between 3 and 50
We found that the levels of completed double-stranded U. There are 11-fold more cells harboring HIV-1 (HXB-
viral DNA were greatly decreased (Figure 5B), closely GFP) that express high levels of Lyt-2(NFATc) versus
reflecting the p24 results, with CsA or FK506 treatment those that express low levels of Lyt-2(NFATc) (see calcu-
lation in figure legend). Thus, there is a strong correlationof PHA-stimulated cells (Figure 5A). Similar levels of the
NFAT Overcomes an HIV-1 Preintegrative Block
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Figure 6. Single Cell Measure of HIV-1 Repli-
cation in Primary CD41 T Cells after NFATc
Expression
Cells transduced with control or NFATc re-
combinant retrovirus were challenged with a
GFP-marked wild-type HIV-1 strain. At 5 days
post infection GFP expression was measured
versus surrogate measure of the transduced
control or NFATc retrovirus expression. (A)
HIV-1 noninfected PHA blasts; (B) nonstimu-
lated control cells; (C) PHA-stimulated con-
trol cells; (D) nonstimulated, NFATc-express-
ing cells. Cells were challenged with HIV-1
(HXB-GFP) at a dose of 105 TCID50 per 106 cells.
Four regions are delineated on each plot: 1.
Lyt2a92 (retrovirus construct expression low
or negative) and GFP2(HIV-1 noninfected);
2. Lyt2a91 (retrovirus expression positive)
and GFP2; 3. Lyt2a92 and GFP1 (HIV-1 in-
fected); 4. Lyt2a91 GFP1. FACS analysis was
performed at 5 days post HIV-1, HXB-GFP
infection. Calculation for NFATc effect on
HIV-1 infectivity and expression was done
by normalizing as follows. HIV-1 positive
cells in the high NFATc-expressing popula-
tion were compared to those expressing
low levels of NFATc. NFATc50-220::HIV-12 5
0.82%.NFATc50-220::HIV-11 5 0.13%; NFATc3-50::
HIV-12 5 14.29%; NFATc3-50::HIV-11 5 0.2%.
The normalization equation was therefore as
follows: [(14.29 4 0.82) 3 0.13] 4 0.2 5 11.3-
fold to correct for the per cell expression of
NFATc.
between the level of Lyt-2(NFATc) expression and HIV-1 provirus establishment and replication did not require
activation-induced T cell proliferation but rather wasinfectivity/expression at the single cell level. There are
cells in Figure 6D that express low apparent levels of competent under a substate of the T cell commitment
programÐnamely that induced to operate after provi-Lyt-2(NFATc) that are HXB-GFP positive. This is likely
due to cells that were previously Lyt-2(NFATc) positive sion of activated transcriptional inducers such as NFATc.
NFATc expression did not drive cell proliferation or ge-but have downregulated its expression over the 2 week
time course of the experiment (see Discussion). neric cell activation status (as measured by several stan-
dard activation markers and cell cycle indicators). Oth-
ers have also observed that human T cell lines growthDiscussion
arrested with aphidicolin or mitomycin C establish pro-
ductive HIV-1 infection (Li et al., 1993).Productive HIV-1 infection of primary CD41 T cells is
blocked in T cells depending upon their activation status Indeed, the G1b phase of the cell cycle in T cells has
been implicated as the time at which HIV-1 can complete(Zack et al., 1990; Bukrinsky et al., 1992; Spina et al.,
1995). Overcoming this block to HIV-1 replication re- most aspects of reverse transcription (Korin and Zack,
1998). However, the G1b phase of the cell cycle wasquires states of T cell activation that include induction
of specific host cellular factors. This necessary signal insufficient to confer competency for completed reverse
transcription (Figure 3D). NFATc provided the necessarycan be provided by the host cellular factor, NFATc,
which is sufficient to initiate a cascade of events leading signals to manifest completed reverse transcription as
well as transcriptional competency. Thus, productiveto completion of reverse transcription of HIV-1 and pro-
ductive viral infection in primary T cells. NFATc, and HIV-1 infection occurs under certain cellular activation
states that are perhaps coincident with certain phaseslikely other transcriptional regulators in T cells (see be-
low), must mediate activation of target loci that them- of the cell cycle which might involve such induced condi-
tions as access to nucleotides or other cellular factorsselves provide a conducive environment for HIV-1 provi-
rus establishment and replication. Dissection of this required for completion of reverse transcription.
cascade of events in T cells begins an understanding
of the key steps HIV-1 must take post entry and prior
to its integration into the cellular DNA of the host. Host Determinants of HIV-1 Parasitism at
Preintegrative and Postintegrative Steps
Although T cell activation and ensuing induction of hostHIV-1 Productive Infection and Cellular Proliferation
Are Separable Events in Primary CD41 T Cells cellular factors are critical for HIV-1 provirus establish-
ment and replication in primary human T cells, theseIt has been long considered that productive HIV-1 infec-
tion and cell proliferation are inseparable events in pri- cellular factors have not been identified. The studies
here show that at least some of these factors are notmary T cells (Zack et al., 1988, 1990). In our hands HIV-1
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constitutively active in primary T cells, but must be acti- mitogen-activated T cells independent of proinflamma-
tory mediation of NF-kB-dependent HIV-1 transcription.vated by induced processes. HIV-1 completes the first
phase of reverse transcription independent in T cells of Of relevance, we have observed that delivery of NF-
kB p50 was unable in normal T cells to lead to HIV-1NFATc activity but can use NFATc to finalize its reverse
transcription process in activated T cells. Other steps replication (data not shown).
Others had previously demonstrated that CsA andthat allow for the nuclear import of the preintegration
complex, and subsequent HIV-1 DNA integration into the FK506 inhibited HIV-1 replication (Karpas et al., 1992;
Thali et al., 1994; Thomson and Bonham, 1995; Borvak ethost genome, were also completed as they apparently
occur concomitantly with overcoming the reverse tran- al., 1996). None of these studies proposed a mechanism
beyond generic inhibition of T cell activation for thescription blockade. However, it is not clear that NFATc
directly regulates aspects of these processes or merely effects observed in their inhibitions. A proposal for a
mechanism for CsA inhibition of HIV-1 concluded thatovercomes a primary block related to a reverse tran-
scription step post first-strand transfer. HIV-1 Gag polyprotein associated with cyclophilin A as
immature virions bud from the cells (Franke et al., 1994;NFATc appears then to be involved in HIV-1 replica-
tion at pre- and postintegrative steps of the HIV-1 life Thali et al., 1994). High concentrations of CsA, no lower
than 1 mg/ml, could inhibit HIV-1 by blocking this interac-cycle. NFATc expression measurably induced HIV-1 rep-
lication both at the level of reverse transcription and at tion. FK506 could not block the interaction and impli-
cated only cyclophilin A, but not FK506-binding protein,the level of HIV-1 mRNA transcription in CD41 T cells.
NFATc binds the kB regulatory elements, synergizes in the Gag maturation process. Previously we had re-
ported that NFATc plays a positive role as a transcriptionwith NF-kB and Tat in transcriptional activation of HIV-1,
and enhances HIV-1 replication in T cell lines (Kinoshita factor regulating HIV-1 gene expression, and we sug-
gested that the inhibition of HIV-1 replication by CsAet al., 1997). NFATc is a sufficient factor, therefore, that
allows establishment of HIV-1 replication in T cells by was due to inhibition of NFATc transcriptional activity
for HIV-1 gene activation (Kinoshita et al., 1997). Thefacilitating completed HIV-1 reverse transcription and
by permitting robust transcription at the HIV-1 promoter. current findings therefore add to the steps at which CsA
can block HIV-1 replication and increase an understand-Provocatively, the data suggest that a single cellular
factor can regulate processes that allow productive ing of cyclophilin's involvement in inhibition and matura-
tion processes for HIV-1.HIV-1 infection in primary CD41 T cells without the ap-
parent contribution of other signaling systems. As much Single cell analysis of HIV-1 replication indicated that
NFATc-induced HIV-1 replication is a direct effect ofas 50% and 80% of HIV-1 reverse transcription and
replication can be ablated with CsA and FK506, respec- NFATc expression in primary cells (Figure 6). In the HIV-
1-positive subpopulation, higher levels of apparenttively, speaking to the potent contribution of the NFAT
complex in HIV-1 provirus establishment and replication NFATc expression led to more infectivity on a per cell
basis. However, in Figure 6D, a cell population that wasin T cells. The synergy data in Figure 3 and the inhibition
results in Figure 5 are evidence, however, that other HIV-1 positive, but lacked apparent NFATc expression,
was present. Though we believe it to be unlikely, thefactors can independently contribute to the provirus es-
tablishment and replication of HIV-1 in PHA-activated T presence of the lower population might mean that solu-
ble factors also effect HIV-1 replication in the non±NFAT-cells. PHA likely activates a number of cellular factors
other than NFAT that account for some of the activation expressing cells. We believe this HIV-1-positive popula-
tion likely had previously expressed NFATc but hadobserved in the presence of the pharmacologic inhibi-
tors. For instance, the transcription factor NF-IL6 (which downregulated expression below the level of FACS de-
tection (such epigenetic down-modulation has been ob-is, interestingly, induced by TNFa) can provide some
replicative capacity for HIV-1, though not to the extent served with retroviral vectors expressing Lyt-2 in long-
term primary T cells culture [Agarwal et al., 1998]). This isobserved with NFATc (data not shown). Thus, common
downstream targets of activation must exist that can likely since we first observed a 43.15% NFATc-positive
population at 7 days post first stimulation (Table 1),induce a T cell state competent for HIV-1 provirus estab-
lishment and replication. Such redundancy in HIV-1 rep- but 2 weeks later this NFATc-positive population was
reduced to 15.44% (Figure 6D). If the single positivelication mechanisms focuses the search for downstream
activated targets that permit the competent replicative HXB-GFP population is comprised of cells that formerly
expressed NFATc, we should be able to predict thestate. Although NFATc induction correlated with PHA
activation of T cells, the NF-kB activation subunit p65/ number of cells that are single positive by this observa-
tion alone. The percentage that putatively lost expres-RelA was present at significant preexisting levels in the
nucleus but was not induced to higher levels after PHA sion (27.7 5 43.15 2 15.44) is 64.2% (0.64 5 27.7 4 43.15)
of the original population of Lyt-2-positive cells in Tablestimulation. The expression of the NF-kB p65 subunit
was also not changed by NFATc expression. This is 1. By multiplying the total population of HIV-1-positive
cells (0.86%) by the percentage drop (0.64) we get anot consistent with a role for NF-kB in PHA-mediated
activation of HIV-1 in T cells. However, it is not inconsis- predicted population of 0.55%. Since the observed pop-
ulation is 0.53%, this supports the proposal that NFATtent with a role for NF-kB in other HIV-1 activation path-
ways in T cells, such as TNFa-activated induction of expression preexisted in these cells and was subse-
quently downregulated. This loss of apparent expres-HIV-1, which others have reported (Chen et al., 1997),
or in TNFa-mediated activation of HIV-1 through NF- sion is also not due to pseudo-transduction of Lyt-2
protein by virion particles, since there is at least a 50%IL6, as suggested above. NFATc and related factors
could therefore influence HIV-1 induction in antigen or recovery of Lyt-2 expression after restimulation (Figure
NFAT Overcomes an HIV-1 Preintegrative Block
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Antibodies6, Agarwal et al., 1998). Also pseudo-transduction is a
PharMingen: 53-6.7 (phycoerythrin [PE] conjugated anti mouse-phenomenon associated with highly concentrated VSV-G
Lyt2a9), UCHT1 (texas red [TR] conjugated anti CD3), RPA-T4pseudotyped virions, not used in these experiments
(Cy7PE conjugated anti CD4), HIT8a (fluorescein isothiocyanate
(Gallardo et al., 1997). Indeed, the absolute Lyt-2 expres- [FITC] conjugated anti CD8), M5E2 (FITC conjugated anti CD14),
sion on the target T cells is comparable to the Lyt-2 HIB19 (PE conjugated anti CD19) and NK-1 (Cy7 allophycocyanin
[APC] conjugated anti CD57). For Western blot analysis, 7A6 andlevels expressed on the retroviral producer cells (data
sc-372 (anti NFATc and anti NF-kB subunit of p65, Santa Cruz).not shown). Pseudo-transduction would require, there-
fore, the recombinant virions to transfer to each cell in
HIV-1 Infectionsthe target population an equivalent of an entire producer
Control CD41 T cells and NFATc-expressing CD41 T cells werecell membrane. This is very unlikely. The data suggest
plated in four wells in 48-well plates (1 3 105/well) in media con-
that once T cells are rendered permissive for HIV-1 by taining 10% FCS at 3 days post second stimulation. HIV-1 infection
NFATc expression, such cells can maintain some as- was performed by incubating cells with NL4-3 (400 TCID50/well in
pects of this permissive status even if transduced NFATc 0.5 ml of culture medium) at 378C for 4 hr. Virus replication was
measured at the indicated days by p24 ELISA. For CsA and FK506expression diminishes.
inhibition assays, the prepared PBMCs were stimulated by PHA (2
mg/ml). CsA or FK506 were added 30 min before PHA stimulation.
Conclusions Three days post stimulation cells were challenged by NL4-3. At 6
We identified NFATc as a host factor that can control days post HIV-1 challenge HIV-1 replication was measured by p24
ELISA, and cellular DNAs were prepared for PCR analysis. For HIV-1productive T- and M-tropic HIV-1 infection in primary
infection and single cell FACS analysis, unsorted control and NFATc-CD41 T cells. NFATc is intimately involved in signaling
expressing cells were infected by HIV-1, HBX-GFP (105 TCID50/106pathways relating to T cell activation. Thus, the same
cells in 2 ml of culture medium) at 378C for 8 hr at 3 days postcellular processes used by T cells to further their com-
secondary stimulation. Cell populations were prestained for dead
mitment processes are parasitized by HIV-1 to complete cells using ethidium monoazide bromide (EMA), stained with anti-
its own early replication steps. Although the target genes Lyt-2 antibody, and fixed with 0.4% glutaraldehyde. Scatter gates
and EMA fluorescence gates were set to exclude cellular debris andfor NFATc that can aid completed reverse transcription
dead cells, respectively. Percentages depicted were calculated asare unknown, a prerequisite to proviral integration, such
a percent of living cells.factors are critical to understanding HIV-1 provirus es-
tablishment mechanisms. This is especially relevant, as
DNA PCR and Southern Blot Hybridizationtherapies aimed at viral targets such as protease and
Total cellular DNA was prepared using QIAamp Blood Kit (QIAGEN).
reverse transcriptase are subject to diminished capacity DNAs were amplified by 35 and 25 rounds for CsA and FK506 inhibi-
with the onset of widespread viral resistance. Blocking tion experiment, respectively, determined to be within linear range.
HIV-1's access to the cellular processes it must parasit- Cycles were 948C, 30 s; 558C, 30 s; and 728C, 60 s under standard
conditions. Standard DNA hybridization conditions were employedize might lead to novel therapies against which HIV-1
for Southern blots. Primer pairs for amplification were as describedcannot readily devise protective mutations.
(von Schwedler et al., 1993). b-actin primers were as follows:
59-ATCATGTTTGAGACCTTCAA and 59-CATCTCTTGCTCGAAGTCCA.
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